{"count": 5, "results": [{"_id": "33179075", "pmid": 33179075, "pmcid": "PMC7684874", "title": "Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression", "journal": "Mol Med Rep", "authors": ["Zhang Y", "Huang J", "Huang Y", "Zhang S", "Wu W", "Long H", "Duan X", "Lai Y", "Wu W"], "date": "2021-01-01T00:00:00Z", "doi": "10.3892/mmr.2020.11678", "meta_date_publication": "2021 Jan", "meta_volume": "23", "meta_issue": "1", "meta_pages": "", "score": 50244.324, "text_hl": "The results indicated that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_tanshinone @CHEMICAL_MESH:C021751 @@@tanshinone I@@@ inhibited @DISEASE_Melanoma @DISEASE_MESH:D008545 @@@melanoma@@@ and @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@renal tumour@@@ cells by regulating @GENE_PARP1 @GENE_142 @@@PARP1@@@ expression, and in addition to the enzyme activity of @GENE_PARP1 @GENE_142 @@@PARP1@@@, the expression of @GENE_PARP1 @GENE_142 @@@PARP1@@@ protein may serve a role in @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumour@@@ progression.", "citations": {"NLM": "Zhang Y, Huang J, Huang Y, Zhang S, Wu W, Long H, Duan X, Lai Y, Wu W. Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression Mol Med Rep. 2021 Jan;23(1):. PMID: 33179075", "BibTeX": "@article{33179075, title={Tanshinone I and simvastatin inhibit melanoma tumour cell growth by regulating poly (ADP ribose) polymerase 1 expression}, author={Zhang Y and Huang J and Huang Y and Zhang S and Wu W and Long H and Duan X and Lai Y and Wu W}, journal={Mol Med Rep}, volume={23}, number={1}}"}}, {"_id": "28507057", "pmid": 28507057, "title": "Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.", "journal": "J Am Soc Nephrol", "authors": ["Stanifer JW", "Charytan DM", "White J", "Lokhnygina Y", "Cannon CP", "Roe MT", "Blazing MA"], "date": "2017-10-01T00:00:00Z", "doi": "10.1681/ASN.2016090957", "meta_date_publication": "2017 Oct", "meta_volume": "28", "meta_issue": "10", "meta_pages": "3034-3043", "score": 50076.105, "text_hl": "Benefit of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@Ezetimibe@@@ Added to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ in @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@Reduced Kidney Function@@@.", "citations": {"NLM": "Stanifer JW, Charytan DM, White J, Lokhnygina Y, Cannon CP, Roe MT, Blazing MA. Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function. J Am Soc Nephrol. 2017 Oct;28(10):3034-3043. PMID: 28507057", "BibTeX": "@article{28507057, title={Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function.}, author={Stanifer JW and Charytan DM and White J and Lokhnygina Y and Cannon CP and Roe MT and Blazing MA}, journal={J Am Soc Nephrol}, volume={28}, number={10}, pages={3034-3043}}"}}, {"_id": "19124121", "pmid": 19124121, "title": "Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S).", "journal": "Atherosclerosis", "authors": ["Huskey J", "Lindenfeld J", "Cook T", "Targher G", "Kendrick J", "Kjekshus J", "Pedersen T", "Chonchol M"], "date": "2009-07-01T00:00:00Z", "doi": "10.1016/j.atherosclerosis.2008.11.010", "meta_date_publication": "2009 Jul", "meta_volume": "205", "meta_issue": "1", "meta_pages": "202-6", "score": 50070.47, "text_hl": "Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@kidney function loss@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@: findings from the Scandinavian @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Survival Study (4S).", "citations": {"NLM": "Huskey J, Lindenfeld J, Cook T, Targher G, Kendrick J, Kjekshus J, Pedersen T, Chonchol M. Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S). Atherosclerosis. 2009 Jul;205(1):202-6. PMID: 19124121", "BibTeX": "@article{19124121, title={Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S).}, author={Huskey J and Lindenfeld J and Cook T and Targher G and Kendrick J and Kjekshus J and Pedersen T and Chonchol M}, journal={Atherosclerosis}, volume={205}, number={1}, pages={202-6}}"}}, {"_id": "27042994", "pmid": 27042994, "title": "Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.", "journal": "Nutr Cancer", "authors": ["Woschek M", "Kneip N", "Jurida K", "Marzi I", "Relja B"], "date": "2016-01-01T00:00:00Z", "doi": "10.1080/01635581.2016.1152383", "meta_date_publication": "2016", "meta_volume": "68", "meta_issue": "3", "meta_pages": "420-7", "score": 50064.086, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Reduces Cancerogenic Potential of @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@Renal Cancer@@@ Cells via @CHEMICAL_geranylgeranyl_pyrophosphate @CHEMICAL_MESH:C002963 @@@Geranylgeranyl Pyrophosphate@@@ and @CHEMICAL_Mevalonic_Acid @CHEMICAL_MESH:D008798 @@@Mevalonate@@@ Pathway.", "citations": {"NLM": "Woschek M, Kneip N, Jurida K, Marzi I, Relja B. Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway. Nutr Cancer. 2016;68(3):420-7. PMID: 27042994", "BibTeX": "@article{27042994, title={Simvastatin Reduces Cancerogenic Potential of Renal Cancer Cells via Geranylgeranyl Pyrophosphate and Mevalonate Pathway.}, author={Woschek M and Kneip N and Jurida K and Marzi I and Relja B}, journal={Nutr Cancer}, volume={68}, number={3}, pages={420-7}}"}}, {"_id": "23690956", "pmid": 23690956, "pmcid": "PMC3656850", "title": "Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway", "journal": "PLoS One", "authors": ["Fang Z", "Tang Y", "Fang J", "Zhou Z", "Xing Z", "Guo Z", "Guo X", "Wang W", "Jiao W", "Xu Z", "Liu Z"], "date": "2013-05-17T00:00:00Z", "doi": "10.1371/journal.pone.0062823", "meta_date_publication": "2013", "meta_volume": "8", "meta_issue": "5", "meta_pages": "e62823", "score": 50058.312, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ induces apoptosis in @<m>DISEASE_Kidney_Neoplasms</m> @DISEASE_MESH:D007680 @@@renal cancer@@@ cells", "citations": {"NLM": "Fang Z, Tang Y, Fang J, Zhou Z, Xing Z, Guo Z, Guo X, Wang W, Jiao W, Xu Z, Liu Z. Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway PLoS One. 2013;8(5):e62823. PMID: 23690956", "BibTeX": "@article{23690956, title={Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway}, author={Fang Z and Tang Y and Fang J and Zhou Z and Xing Z and Guo Z and Guo X and Wang W and Jiao W and Xu Z and Liu Z}, journal={PLoS One}, volume={8}, number={5}, pages={e62823}}"}}]}